Lactobacillus fermentum CECT5716 and Reduced Gastrointestinal Infections

• Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis.

  • 2021-06-30
  • Review · n = 435
  • Microorganisms 9(7)
  • • Belén Pastor-Villaescusa
    • Ruth Blanco-Rojo
    • Mónica Olivares

  • PubMed: 34208893
  • DOI: 10.3390/microorganisms9071412

  1 Insight on

  • Reduced Gastrointestinal Infections

  • High evidence
  • Infants

  There was a significant reduction in the incidence rate of GIs for those receiving L. fermentum CECT5716 compared with those receiving placebo (IRR: 0.52, 95% CI: 0.36-0.74, p = 0.0004).

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes

  Dose

  1 × 10^9 to 8.4 × 10^8 cfu/day